• Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
Investing

Anthropic valued at over $61 billion in latest funding round

by March 3, 2025
by March 3, 2025
anthropic valued at $61.5 billion in latest funding round

The post Anthropic valued at over $61 billion in latest funding round appeared first on Invezz

0 comment
0
FacebookTwitterPinterestEmail

previous post
Quectel Unveils Its New Smart Module SC200V at MWC 2025, Unlocking New Possibilities for High-Performance and Advanced Multi-Media Smart Devices
next post
Interview: ‘No one, not even us, can see what you are doing’ — NymVPN’s CSO ahead of launch

Related Posts

Why is Arcellx stock up 80% today? Gilead’s...

February 23, 2026

Finland’s IQM leads Europe’s quantum push with US...

February 23, 2026

We predicted Blue Owl stock price crash: what’s...

February 23, 2026

Merck creates separate oncology arm ahead of Keytruda...

February 23, 2026

Royal Bank of Canada stock double-tops ahead of...

February 23, 2026

Eli Lilly bets on multi-dose Zepbound pen in...

February 23, 2026

US stocks open flat after Trump raises global...

February 23, 2026

Almirall profit quadruples in 2025 as dermatology fuels...

February 23, 2026

Vanda stock’s explosive rally may be more hype...

February 23, 2026

Why is Nvidia stock soaring before Q4 earnings?...

February 23, 2026

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent Posts

  • Why is Arcellx stock up 80% today? Gilead’s $7.8B answer

    February 23, 2026
  • Finland’s IQM leads Europe’s quantum push with US listing plan

    February 23, 2026
  • We predicted Blue Owl stock price crash: what’s next?

    February 23, 2026
  • Merck creates separate oncology arm ahead of Keytruda patent loss

    February 23, 2026
  • Royal Bank of Canada stock double-tops ahead of Q1 earnings

    February 23, 2026
  • Eli Lilly bets on multi-dose Zepbound pen in GLP-1 retention push

    February 23, 2026

Editors’ Picks

  • 1

    Pop Mart reports 188% profit surge, plans aggressive global expansion

    March 26, 2025
  • 2

    New FBI leader Kash Patel tapped to run ATF as acting director

    February 23, 2025
  • 3

    Meta executives eligible for 200% salary bonus under new pay structure

    February 21, 2025
  • 4

    Anthropic’s newly released Claude 3.7 Sonnet can ‘think’ as long as the user wants before giving an answer

    February 25, 2025
  • 5

    Walmart earnings preview: What to expect before Thursday’s opening bell

    February 20, 2025
  • ‘The Value of Others’ Isn’t Especially Valuable

    April 17, 2025
  • 7

    Cramer reveals a sub-sector of technology that can withstand Trump tariffs

    March 1, 2025

Categories

  • Economy (4,235)
  • Editor's Pick (480)
  • Investing (564)
  • Stock (2,747)
  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Portfolio Performance Today
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Copyright © 2025 Portfolioperformancetoday.com All Rights Reserved.

Read alsox

Commodity wrap: gold and silver end volatile...

February 9, 2026

AMD stock jumps 4% on Friday: is...

January 25, 2026

Long ACN: bullish reversal from ascending triangle...

April 29, 2025